REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pro.Med.Cs Praha A.S. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pro.Med.Cs Praha A.S. Profile Updated: November 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PRO.MED.CS Praha a.s. is specialized in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain, in addition we also have medicines for mental disturbances, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

Headquarters
Telcska 377/1
Prague; The City of Prague; Postal Code: 14000

Contact Details: Purchase the Pro.Med.Cs Praha A.S. report to view the information.

Website: http://www.promed.cz

Basic Information
Total Employees:
Purchase the Pro.Med.Cs Praha A.S. report to view the information.
Outstanding Shares:
Purchase the Pro.Med.Cs Praha A.S. report to view the information.
Registered Capital:
Purchase the Pro.Med.Cs Praha A.S. report to view the information.
Financial Auditors:
Purchase the Pro.Med.Cs Praha A.S. report to view the information.
Incorporation Date:
February 01, 1989
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Vice Chairman of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Chairman of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Sibex Line D.O.O. Beograd (Serbia)
Company Performance
Financial values in the chart are available after Pro.Med.Cs Praha A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
2.08%▲
Total operating revenue
2.13%▲
Operating profit (EBIT)
19.94%▲
EBITDA
27.76%▲
Net Profit (Loss) for the Period
24.33%▲
Total assets
17.87%▲
Total equity
12.55%▲
Operating Profit Margin (ROS)
4.89%▲
Net Profit Margin
4.7%▲
Return on Equity (ROE)
2.27%▲
Quick Ratio
-2.38%▼
Cash Ratio
0.4%▲

Similar companies

Zentiva, K.S.
 
Teva Czech Industries S.R.O.
Novartis S.R.O.
 
Hartmann - Rico A.S.
Teva Pharmaceuticals Cr, S.R.O.
 
Lohmann & Rauscher, S.R.O.
Novavax Cz A.S.
 
Boehringer Ingelheim, Spol. S R.O.
Janssen-Cilag S.R.O.
 
Bioveta, A.S.
Ferring-Leciva, A.S.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo